Elif I. Ekinci

Fitzroy, VIC, Australia

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 224 publications

Survodutide Once Weekly for the Treatment of Adults with Obesity.

Survodutide Once Weekly for the Treatment of Adults with Obesity.

Journal: The New England journal of medicine
Published: June 08, 2026

The Emerging Role of Glucagon-like Peptide 1 (GLP-1)-Based Medications in the Treatment of Heart Failure, with a Focus on Heart Failure with Preserved or Mildly Reduced Ejection Fraction.

The Emerging Role of Glucagon-like Peptide 1 (GLP-1)-Based Medications in the Treatment of Heart Failure, with a Focus on Heart Failure with Preserved or Mildly Reduced Ejection Fraction.

Journal: Medicina (Kaunas, Lithuania)
Published: March 27, 2026

Ketone Profiles in Community-Dwelling Adults with Type 1 Diabetes Using Continuous Ketone Monitoring.

Ketone Profiles in Community-Dwelling Adults with Type 1 Diabetes Using Continuous Ketone Monitoring.

Journal: Diabetes technology & therapeutics
Published: February 13, 2026

Ketone Profiles in Community-Dwelling Adults with Type 1 Diabetes Using Continuous Ketone Monitoring.

Ketone Profiles in Community-Dwelling Adults with Type 1 Diabetes Using Continuous Ketone Monitoring.

Journal: Diabetes technology & therapeutics
Published: February 13, 2026

Multi-Parametric Magnetic Resonance Imaging to Assess Empagliflozin Effect on the Kidneys in People With Type 2 Diabetes Mellitus: A Pilot Clinical Trial.

Multi-Parametric Magnetic Resonance Imaging to Assess Empagliflozin Effect on the Kidneys in People With Type 2 Diabetes Mellitus: A Pilot Clinical Trial.

Journal: Diabetes, obesity & metabolism
Published: February 06, 2026

Dual Glucagon and GLP-1 Receptor Agonist Survodutide Improves Biomarkers of Beta-Cell Function and Insulin Sensitivity in People With Type 2 Diabetes or Living With Overweight/Obesity.

Dual Glucagon and GLP-1 Receptor Agonist Survodutide Improves Biomarkers of Beta-Cell Function and Insulin Sensitivity in People With Type 2 Diabetes or Living With Overweight/Obesity.

Journal: Diabetes, obesity & metabolism
Published: January 21, 2026

The impact of automated insulin delivery on glucose management in people with diabetes and advanced chronic kidney disease.

The impact of automated insulin delivery on glucose management in people with diabetes and advanced chronic kidney disease.

Journal: Diabetologia
Published: January 09, 2026

Survey of glucose levels in adults with T1DM attending clinic using automated insulin delivery (AID) devices compared with manual insulin delivery.

Survey of glucose levels in adults with T1DM attending clinic using automated insulin delivery (AID) devices compared with manual insulin delivery.

Journal: Diabetes research and clinical practice
Published: December 30, 2025

Characteristics and outcomes of diabetes emergencies in nonagenarians admitted to ICU: a binational retrospective cohort study.

Characteristics and outcomes of diabetes emergencies in nonagenarians admitted to ICU: a binational retrospective cohort study.

Journal: Frontiers in clinical diabetes and healthcare
Published: December 17, 2025

Safety, feasibility, and dose-dependent metabolic effects of endoscopic duodenal pulsed electric field therapy in adults with type 2 diabetes: Results from two multicentre proof-of-concept studies.

Safety, feasibility, and dose-dependent metabolic effects of endoscopic duodenal pulsed electric field therapy in adults with type 2 diabetes: Results from two multicentre proof-of-concept studies.

Journal: Diabetes, obesity & metabolism
Published: November 21, 2025

Limitation of existing GFR estimating equations and application of artificial intelligence in improving GFR estimation and chronic kidney disease progression in people with diabetes.

Limitation of existing GFR estimating equations and application of artificial intelligence in improving GFR estimation and chronic kidney disease progression in people with diabetes.

Journal: Diabetes research and clinical practice
Published: November 05, 2025

Effect of preoperative SGLT2 inhibitor use on postoperative acute kidney injury in patients with type 2 diabetes undergoing surgery: A causal inference study using routinely collected data.

Effect of preoperative SGLT2 inhibitor use on postoperative acute kidney injury in patients with type 2 diabetes undergoing surgery: A causal inference study using routinely collected data.

Journal: Diabetes, obesity & metabolism
Published: October 29, 2025
Showing 1-12 of 224

Last Updated: 09/26/2026